World Journal of Surgery

, Volume 36, Issue 2, pp 392–400 | Cite as

Adverse Outcomes in Patients with Postoperative Ascites after Liver Resection for Hepatocellular Carcinoma

  • Kun-Ming Chan
  • Chen-Fang Lee
  • Ting-Jung Wu
  • Hong-Shiue Chou
  • Ming-Chin Yu
  • Wei-Chen Lee
  • Miin-Fu Chen



Postoperative ascites (POA) is a common complication after liver resection (LR). The aim of the present study was to identify the risk factors for developing POA and to evaluate its clinical significance in the prognosis of patients with hepatocellular carcinoma (HCC).


We performed a retrospective analysis of data obtained from 651 patients who underwent LR for the treatment of HCC between January 2001 and July 2005. The patients selected for the study were categorized and analyzed on the basis of the presence or absence of POA.


Overall, 166 (25.5%) patients developed POA. A multivariate logistic regression analysis identified that five significant factors—cirrhotic liver, high indocyanine green retention, portal hypertension, hypoalbuminemia, and extent of LR—were associated with the development of POA. The recurrence-free survival and overall survival of patients with POA were significantly lower than those of patients without POA. The 5-year recurrence-free survival rates of patients with intractable POA over those of patients without POA were 31.7% versus 36.1%, and the corresponding 5-year overall survival rates were 17.4% versus 57.0%. The relative risk of mortality within 1 year in patients with POA was 2.4 times (95% confidence interval, 1.76–3.27; p < 0.001) higher than that in patients without POA.


A nomogram for predicting the probability of POA after LR for HCC was constructed on the basis of the identified risk factors, which may be used for risk-stratifying patients who may or may not benefit from surgical resection. Because patients with POA after LR show a high incidence of HCC recurrence and mortality risk, those with intractable ascites should be considered for prompt liver transplantation.


Overall Survival Liver Resection Portal Hypertension Overall Survival Rate Cirrhotic Liver 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRefGoogle Scholar
  2. 2.
    Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406PubMedCrossRefGoogle Scholar
  3. 3.
    Grazi GL, Ercolani G, Pierangeli F et al (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234:71–78PubMedCrossRefGoogle Scholar
  4. 4.
    Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–799PubMedCrossRefGoogle Scholar
  5. 5.
    Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198PubMedCrossRefGoogle Scholar
  6. 6.
    Wei AC, Tung-Ping PR, Fan ST et al (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41PubMedCrossRefGoogle Scholar
  7. 7.
    Salerno F, Borroni G, Moser P et al (1993) Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 88:514–519PubMedGoogle Scholar
  8. 8.
    Rimola A, Garcia-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32:142–153PubMedCrossRefGoogle Scholar
  9. 9.
    Ikeda Y, Kanematsu T, Matsumata T et al (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14–16PubMedGoogle Scholar
  10. 10.
    Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51PubMedCrossRefGoogle Scholar
  11. 11.
    Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRefGoogle Scholar
  12. 12.
    Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRefGoogle Scholar
  13. 13.
    Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10(2 Suppl 1):S46–S52Google Scholar
  14. 14.
    Lee CF, Yu MC, Kuo LM et al (2007) Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J 30:333–338PubMedGoogle Scholar
  15. 15.
    Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338PubMedCrossRefGoogle Scholar
  16. 16.
    Moore KP, Wong F, Gines P et al (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38:258–266PubMedCrossRefGoogle Scholar
  17. 17.
    Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370PubMedCrossRefGoogle Scholar
  18. 18.
    Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43(2 Suppl 1):S45–S53Google Scholar
  19. 19.
    Gines P, Cardenas A, Arroyo V et al (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654PubMedCrossRefGoogle Scholar
  20. 20.
    Yeh CN, Chen MF, Lee WC et al (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195–202PubMedCrossRefGoogle Scholar
  21. 21.
    Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P et al (2001) A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 34:46–52PubMedCrossRefGoogle Scholar
  22. 22.
    Heuman DM, Abou-Assi SG, Habib A et al (2004) Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40:802–810PubMedGoogle Scholar
  23. 23.
    Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2011

Authors and Affiliations

  • Kun-Ming Chan
    • 1
  • Chen-Fang Lee
    • 1
  • Ting-Jung Wu
    • 1
  • Hong-Shiue Chou
    • 1
  • Ming-Chin Yu
    • 1
  • Wei-Chen Lee
    • 1
  • Miin-Fu Chen
    • 1
  1. 1.Division of Liver and Organs Transplantation Surgery, Department of General SurgeryChang Gung Memorial Hospital at Linkou, Chang Gung University College of MedicineTaoyuanTaiwan

Personalised recommendations